Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA prima-1 CTRPv2 pan-cancer AAC 0.084 0.007
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.092 0.007
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.007
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.086 0.007
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.099 0.008
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.14 0.008
mRNA STF-31 CTRPv2 pan-cancer AAC 0.092 0.008
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.008
mRNA FK866 CTRPv2 pan-cancer AAC 0.097 0.009
mRNA B02 CTRPv2 pan-cancer AAC 0.092 0.009
Download CSV